For example, the proportion of CD3+CD8+ cytotoxic T cells was higher in T1 than in T2 cancer, and the percentage of CD11b+CD14−/CD33+CD14− PMN-MDSCs was lower in T1 than in T2 cancer [42]. The gene discussed is CD33; the disease is cancer.